Measuring Alcohol Consumption Using Timeline Followback in Non-Treatment-Seeking Medical Clinic Patients With and Without HIV Infection: 7-, 14-, or 30-day Recall
Measuring Alcohol Consumption Using Timeline Followback in Non-Treatment-Seeking Medical Clinic Patients With and Without HIV Infection: 7-, 14-, or 30-day Recall
复制标题
DOI：
10.15288/jsad.2013.74.500
复制
发表时间：
2013-05-01
影响因子：
3.4
通讯作者：
Bryant, Kendall
中科院分区：
文献类型：
--
作者：
Fiellin, David A.;McGinnis, Kathleen A.;Bryant, Kendall
目的：酒精摄入量的测量是艾滋病毒高危或感染患者研究的重要组成部分。诸如时间线回传(TLFB)等日常评估措施已经得到验证，但最佳时间窗口及其在非求医医疗诊所受试者和艾滋病毒携带者中的表现尚不清楚。方法：在普通医疗或传染病诊所接受医疗护理的1,519名艾滋病毒感染者和1,612名未感染艾滋病毒的男性中，我们使用Spearman相关系数比较了通过电话获得的7天、14天和30天的TLFB报告与饮酒的相关性。为了评估7天、14天和30天重度饮酒报告之间的一致性，我们评估了符合率、敏感度和kappa统计数据，并将30天报告作为金标准。结果：TLFB间期越长，重度饮酒的估计患病率越高(7天：6.3%；14天：8.0%；30天：9.5%)。与30天TLFB的相关系数在14天(.94)高于7天(.86，p<；.001)，在HIV感染者(.94对.86，p<；.001)和未感染(.95对.87，p<；001)之间的相关系数更高。艾滋病病毒感染状况的相关性也类似。当考虑到总体和HIV状况时，敏感度、符合百分比和kappa统计对于基于14天的重度饮酒比7天的更好。结论：与30天相比，非就诊的HIV感染者和非HIV感染者饮酒14天的TLFB优于7天。(J螺柱.酒精类毒品，74,500-504,2013年)
Objective: The measurement of alcohol consumption is an essential component of research in patients at risk for or infected with HIV. Daily estimation measures such as the Timeline Followback (TLFB) have been validated, yet the optimal time window and its performance in non-treatment-seeking medical clinic subjects and among those with HIV are not known. Method: In 1,519 HIV-infected and 1,612 uninfected men receiving medical care in general medical or infectious disease clinics, we compared the association between 7-, 14-, and 30-day TLFB reports, obtained via telephone, of alcohol consumption using Spearman's correlation coefficients. To evaluate agreement between 7-, 14-, and 30-day reports of heavy episodic drinking, we evaluated percent agreement, sensitivity, and kappa statistics, considering 30-day report as the gold standard. Results: The estimated prevalence of heavy episodic drinking was progressively higher for longer TLFB intervals (7 days: 6.3%; 14 days: 8.0%; 30 days: 9.5%). Correlation coefficients with 30-day TLFB were higher for 14 days (.94) than for 7 days (.86) overall (p < .001) and among HIV-infected (.94 vs. .86, p < .001) and uninfected (.95 vs. .87, p < 001). Correlations were similar by HIV status. When considered overall and by HIV status, the sensitivity, percent agreement, and kappa statistics are better for heavy episodic drinking based on 14 days compared with 7 days. Conclusions: A TLFB for alcohol consumption of 14 days is preferable to 7 days for non-treatment-seeking patients in medical clinics with and without HIV infection when compared with 30 days. (J Stud. Alcohol Drugs, 74, 500-504, 2013)